Cognition Therapeutics
Stock Forecast, Prediction & Price Target
Cognition Therapeutics Financial Estimates
Cognition Therapeutics Revenue Estimates
Cognition Therapeutics EBITDA Estimates
Cognition Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $20.96M Low: $20.96M High: $20.96M avg. 0% | Avg: $71.91M Low: $71.91M High: $71.91M avg. 243.02% |
Net Income
% change YoY
| $-10.28M N/A | $757K 107.36% | $-25.78M -3506.60% | Avg: $-50.92M Low: $-56.45M High: $-11.41M avg. -97.48% | Avg: $-73.42M Low: $-85.28M High: $-13.81M avg. -44.18% | Avg: $-36.63M Low: $-36.63M High: $-36.63M avg. 50.10% | Avg: $-21.92M Low: $-21.92M High: $-21.92M avg. 40.16% |
EBITDA
% change YoY
| $-13.38M N/A | $-21.13M -57.92% | $-25.50M -20.70% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.46 N/A | $0.03 105.67% | -$0.86 -3395.01% | Avg: -$1.03 Low: -$1.88 High: -$0.38 avg. -19.76% | Avg: -$1.34 Low: -$2.84 High: -$0.46 avg. -29.85% | Avg: -$1.22 Low: -$1.22 High: -$1.22 avg. 8.78% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. 40.16% |
Operating Expenses
% change YoY
| $11.15M N/A | $21.33M 91.31% | $50.72M 137.76% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Cognition Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -12.84% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -56.45M, average is -50.92M and high is -11.41M.
What is Cognition Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 60.75% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Cognition Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -0.16% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.88, average is -$1.03 and high is $-0.38.